These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33231168)

  • 21. Sodium oxybate for cataplexy.
    Lemon MD; Strain JD; Farver DK
    Ann Pharmacother; 2006 Mar; 40(3):433-40; quiz 581-2. PubMed ID: 16507620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
    Huang YS; Guilleminault C
    Pediatr Neurol; 2009 Jul; 41(1):9-16. PubMed ID: 19520267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of long-term use of sodium oxybate for narcolepsy with cataplexy in routine clinical practice.
    Drakatos P; Lykouras D; D'Ancona G; Higgins S; Gildeh N; Macavei R; Rosenzweig I; Steier J; Williams AJ; Muza R; Kent BD; Leschziner G
    Sleep Med; 2017 Jul; 35():80-84. PubMed ID: 28619187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy.
    Sarfraz N; Okuampa D; Hansen H; Alvarez M; Cornett EM; Kakazu J; Kaye AM; Kaye AD
    Health Psychol Res; 2022; 10(3):34222. PubMed ID: 35774905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Advances in the diagnosis and treatment of narcolepsy-cataplexy syndrome].
    de Vicente Alvarez-Manzaneda EE
    Rev Neurol; 2008 May 1-15; 46(9):550-6. PubMed ID: 18446698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of narcolepsy.
    Didato G; Nobili L
    Expert Rev Neurother; 2009 Jun; 9(6):897-910. PubMed ID: 19496692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Accountability of anti-cholinergic drugs in increase of psychotic episodes: A case of tropatepine overdose].
    Jaussaud C; Lebain P; Tessiot L; Dollfus S; Madigand J
    Rev Med Interne; 2021 Feb; 42(2):127-130. PubMed ID: 33168356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy.
    Roth T; Dauvilliers Y; Guinta D; Alvarez-Horine S; Dynin E; Black J
    J Sleep Res; 2017 Aug; 26(4):407-414. PubMed ID: 27807903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
    Knudsen S; Gammeltoft S; Jennum PJ
    Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials.
    Meskill GJ; Davis CW; Zarycranski D; Doliba M; Schwartz JC; Dayno JM
    CNS Drugs; 2022 Jan; 36(1):61-69. PubMed ID: 34935103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Narcolepsy: clinical approach to etiology, diagnosis, and treatment.
    Koziorynska EI; Rodriguez AJ
    Rev Neurol Dis; 2011; 8(3-4):e97-106. PubMed ID: 22249574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
    Poza-Aldea JJ
    Rev Neurol; 2009 Jan 1-15; 48(1):27-31. PubMed ID: 19145563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Criteria for gauging response to sodium oxybate for narcolepsy.
    Steffen AD; Lai C; Weaver TE
    J Sleep Res; 2018 Aug; 27(4):e12628. PubMed ID: 29205601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy.
    Bogan RK; Roth T; Schwartz J; Miloslavsky M
    J Clin Sleep Med; 2015 Apr; 11(4):427-32. PubMed ID: 25580605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children.
    Aran A; Einen M; Lin L; Plazzi G; Nishino S; Mignot E
    Sleep; 2010 Nov; 33(11):1457-64. PubMed ID: 21102987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Narcolepsy with cataplexy].
    Dauvilliers Y; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
    Zeitzer JM; Nishino S; Mignot E
    Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Narcolepsy: a new perspective on diagnosis and treatment].
    Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Narcolepsy.
    Barateau L; Lopez R; Dauvilliers Y
    Curr Treat Options Neurol; 2016 Oct; 18(10):43. PubMed ID: 27549768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An interesting case of late age at onset of narcolepsy with cataplexy.
    Krishnamurthy VB; Nallamothu V; Singareddy R
    J Clin Sleep Med; 2014 Feb; 10(2):203-5. PubMed ID: 24533004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.